263 related articles for article (PubMed ID: 35929507)
21. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
Maurice DH
Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
[TBL] [Abstract][Full Text] [Related]
22. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
[TBL] [Abstract][Full Text] [Related]
23. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
24. Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary.
Velardez MO; De Laurentiis A; del Carmen Díaz M; Lasaga M; Pisera D; Seilicovich A; Duvilanski BH
Eur J Endocrinol; 2000 Aug; 143(2):279-84. PubMed ID: 10913949
[TBL] [Abstract][Full Text] [Related]
25. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.
Horvath A; Korde L; Greene MH; Libe R; Osorio P; Faucz FR; Raffin-Sanson ML; Tsang KM; Drori-Herishanu L; Patronas Y; Remmers EF; Nikita ME; Moran J; Greene J; Nesterova M; Merino M; Bertherat J; Stratakis CA
Cancer Res; 2009 Jul; 69(13):5301-6. PubMed ID: 19549888
[TBL] [Abstract][Full Text] [Related]
26. Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition.
Azevedo MF; Horvath A; Bornstein ER; Almeida MQ; Xekouki P; Faucz FR; Gourgari E; Nadella K; Remmers EF; Quezado M; de Alexandre RB; Kratz CP; Nesterova M; Greene MH; Stratakis CA
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1393-400. PubMed ID: 23771924
[TBL] [Abstract][Full Text] [Related]
27. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
28. Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.
Yuasa K; Ohgaru T; Asahina M; Omori K
Eur J Biochem; 2001 Aug; 268(16):4440-8. PubMed ID: 11502204
[TBL] [Abstract][Full Text] [Related]
29. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells.
Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A
Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.
Wong ML; Whelan F; Deloukas P; Whittaker P; Delgado M; Cantor RM; McCann SM; Licinio J
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15124-9. PubMed ID: 17008408
[TBL] [Abstract][Full Text] [Related]
31. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
32. The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection.
Shu T; Zhou Y; Yan C
Vascul Pharmacol; 2024 Mar; 154():107278. PubMed ID: 38262506
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice.
Hegde S; Capell WR; Ibrahim BA; Klett J; Patel NS; Sougiannis AT; Kelly MP
Neuropsychopharmacology; 2016 Nov; 41(12):2920-2931. PubMed ID: 27339393
[TBL] [Abstract][Full Text] [Related]
35. Expression of PDE11A in normal and malignant human tissues.
D'Andrea MR; Qiu Y; Haynes-Johnson D; Bhattacharjee S; Kraft P; Lundeen S
J Histochem Cytochem; 2005 Jul; 53(7):895-903. PubMed ID: 15995148
[TBL] [Abstract][Full Text] [Related]
36. Enzyme assays for cGMP hydrolyzing phosphodiesterases.
Rybalkin SD; Hinds TR; Beavo JA
Methods Mol Biol; 2013; 1020():51-62. PubMed ID: 23709025
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
Faucz FR; Horvath A; Rothenbuhler A; Almeida MQ; Libé R; Raffin-Sanson ML; Bertherat J; Carraro DM; Soares FA; Molina Gde C; Campos AH; Alexandre RB; Bendhack ML; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E135-40. PubMed ID: 20881257
[TBL] [Abstract][Full Text] [Related]
38. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
39. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
40. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
Ahmad F; Murata T; Shimizu K; Degerman E; Maurice D; Manganiello V
Oral Dis; 2015 Jan; 21(1):e25-50. PubMed ID: 25056711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
